Latest Lead News

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Ausmon Resources reports promising assay results from recent drilling programs targeting rare earth elements in South Australia and base metals near Broken Hill, NSW, setting the stage for expanded exploration.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.

Lodestar Minerals has completed a pivotal drilling program at its Darwin Project in Chile, confirming promising gold and copper mineralisation. The company also announced a $2.7 million capital raise to fund ongoing exploration and corporate activities.

Babylon Pump & Power capped FY25 with its strongest rental segment performance and is poised to expand significantly following imminent acquisitions of Matrix Hydro Services and Blue Hire.

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

Chilwa Minerals has significantly boosted its Mineral Resource Estimate by 85% to 110 million tonnes, with a majority now in the Indicated category, underpinning ongoing feasibility studies and rare earth exploration in Malawi.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

Viridis Mining and Minerals has been selected for up to US$903 million in Brazilian government funding to advance its Colossus Rare Earth Project, while delivering Brazil’s first locally sourced rare earth oxides and posting robust Pre-Feasibility Study results.